Complement C3 in serum and plasma, as measured by radial immunodiffusion with four commercial kits.

1976 ◽  
Vol 22 (2) ◽  
pp. 267-269 ◽  
Author(s):  
A O Vladutiu ◽  
B M Winiarski

Abstract Quantitation of the C3 component of complement by single radial immunodiffusion is subject to error because the C3 molecule has several antigenic determinants and anti-C3 sera differ in their specificity to these determinants. C3 was measured in plasma (ethylenediaminetetraacetate anticoagulant) and serum, in five normal individuals, by use of four such commercial kits. The effects of ethylenediaminetetraacetate and of incubation at -20, 4, and 37 degrees C for 1, 2, and 7 days were investigated. We found wide variations in C3 in the same sample, as measured with different kits. Incubation for longer than 48 h at 4 degrees C changed C3 concentrations as compared to those in fresh samples. Reference sera for C3 assay and standardized procedures for sample processing are both essential to valid results.

1974 ◽  
Vol 20 (6) ◽  
pp. 676-681 ◽  
Author(s):  
Gerhard M Kostner ◽  
Walter Petek ◽  
Anton Holasek

Abstract Lipoprotein-X, an abnormal lipoprotein that is specific for cholestasis, was quantitated by immunochemical methods. Interfering lipoproteins also present in normal serum and sharing antigenic determinants with lipoprotein-X were removed before the sample was applied, by precipitation with purified anti-lipoprotein B or a γ-globulin fraction of specific lipoprotein B antiserum. On Laurell electrophoresis, peak height was linearly related to lipoprotein-X concentration in the range 0.20-10 g/liter of serum. Sensitivity could be increased further by staining the plates. The coefficient of variation was less than 5%. Single radial immunodiffusion (Mancini et al. technique) was somewhat less sensitive and accurate. Results were available after 3 h by Laurell's electroimmunodiffusion technique, and after 72 h by the technique of Mancini et al. Equivalent results were obtained for samples of lipoprotein-X of extrahepatic or intrahepatic origin.


1986 ◽  
Vol 161 (3) ◽  
pp. 275-282 ◽  
Author(s):  
Koji Itakura ◽  
Takeyasu Matsudate ◽  
Takato Sakurai ◽  
Shunichi Hashimoto ◽  
Kazue Ito ◽  
...  

1987 ◽  
Author(s):  
Diane Nugent

Platelet membrane glycoproteins (GP) express anumber of antigenic determinants important in theetiology of autoimmune thrombocytopenia. Sensitization to GPIb, although not the most frequent cause of ITP, leads to a particularly severe form ofthe disease. We have identified a number of casesof ITP in which GPIb bears the relevant immunogen. Using GPIb-specific autoantibodies isolated from the plasma of one such patient, we have produced a number of rabbit polyclonal and murine monoclonal anti-idiotypic antibodies. These antibodies recognize an idiotype expressed on the IgM antibody of this patient as well as IgG or IgM antibodies from several other patients with ITP, all of which can be shown to bind specifically to GPIb. Statistical analysis of a series of plasmas from normal individuals and thrombocytopenic patients demonstrated that there is a very strong correlation between the presence of the idiotype and GPIb reactivity, (p < 0.00001). These anti-idiotypic antibodies are useful for the detection and characterization of GPIb-specific antibodies in the sera of patients with a clinically severe form of ITP. The classification of patients bearing this idiotype in their plasma may be useful in predicting disease outcome, thus identifying a group of ITP patients in whom more aggressive therapeutic regimens may be indicated. The use of these reagents and the development of human B lymphoblastoid cell lines producing monoclonal anti-GPIb antibodies will serve to elucidate the clonal origin and cellular regulation of autoantibody production in this disease


Sign in / Sign up

Export Citation Format

Share Document